{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T15:21:43Z","timestamp":1759332103420},"reference-count":0,"publisher":"Oxford University Press (OUP)","issue":"14","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2009,7,15]]},"DOI":"10.1093\/jnci\/djp216","type":"journal-article","created":{"date-parts":[[2009,7,8]],"date-time":"2009-07-08T03:33:22Z","timestamp":1247024002000},"page":"980-982","source":"Crossref","is-referenced-by-count":9,"title":["JAK2 Inhibitors: Not the Next Imatinib But Researchers See Other Possibilities"],"prefix":"10.1093","volume":"101","author":[{"given":"Ken","family":"Garber","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2009,7,15]]},"container-title":["JNCI: Journal of the National Cancer Institute"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/jnci\/article-pdf\/101\/14\/980\/18085204\/djp216.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,8,24]],"date-time":"2017-08-24T11:05:41Z","timestamp":1503572741000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jnci\/article-lookup\/doi\/10.1093\/jnci\/djp216"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,7,15]]},"references-count":0,"journal-issue":{"issue":"14","published-online":{"date-parts":[[2009,7,15]]},"published-print":{"date-parts":[[2009,7,15]]}},"URL":"https:\/\/doi.org\/10.1093\/jnci\/djp216","relation":{},"ISSN":["0027-8874","1460-2105"],"issn-type":[{"value":"0027-8874","type":"print"},{"value":"1460-2105","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,7,15]]}}}